Skip to content

Jejunal Neuroendocrine Tumor G1 C1334296

Published: July 22, 2026Updated: August 20, 2026

A slow-growing tumor arising from hormone-producing cells in the jejunum. These neuroendocrine tumors may cause symptoms from hormone release. Surgery and other therapies are often effective.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Intermittent abdominal pain

(gastrointestinal)

Diarrhea

(gastrointestinal)

Facial flushing

(gastrointestinal)

Carcinoid heart disease (valvular dysfunction)

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complete Surgical Excision

Curative surgical removal of the well-differentiated G1 neuroendocrine tumor with adequate margins and regional lymph node assessment for proper staging.

surgical
2

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Somatostatin Analog Therapy

Long-acting somatostatin injections to control hormone-related symptoms such as diarrhea and flushing while also providing potential anti-tumor effects.

medication

Additional treatment options

Biochemical and Imaging Follow-up

Regular chromogranin A monitoring and cross-sectional imaging to assess treatment response and detect early progression in well-differentiated tumors.

monitoring

Everolimus Targeted Therapy

mTOR inhibitor medication used for progressive well-differentiated neuroendocrine tumors when standard therapies are insufficient to control disease progression.

medication

Symptom-Directed Dietary Management

Customized diet modifications to manage carcinoid syndrome symptoms including trigger food avoidance and small frequent meals to reduce dumping-like symptoms.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Jejunal Neuroendocrine Tumor G1 C1334296?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shah MH, Goldner WS, Halfdanarson TR, et al. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2024. J Natl Compr Canc Netw. 2024.

guideline2024
2

Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2023.

review2023
3

Mann GB, Garcia IA, Lee JH, et al. Long-term outcomes after surgical resection of jejunal and ileal neuroendocrine tumors. Ann Surg Oncol. 2020.

other2020
4

Zhou Z, Chen J, Liu Y, et al. Clinicopathological features and prognosis of small bowel neuroendocrine tumors: A systematic review and meta-analysis. Cancers (Basel). 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Jejunal Neuroendocrine Tumor G1 C1334296. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy